#HVO hVIVO PLC – Proposed Secondary Placing of Ordinary Shares February 14, 2024 – Posted in: hVIVO (HVO)

hVIVO plc (AIM & Euronext: HVO), the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that it has been informed by certain Directors of the Company of their intention to sell, in aggregate, not less than 14,000,000 ordinary shares of 0.1 pence each (“Ordinary Shares”) in the capital of Company (the “Placing Shares”), representing approximately 25% of their current shareholding, at a price of 28 pence per Placing…

#TSP TruSpine Technologies PLC – Proposed Director Appointments & Update September 18, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces the proposed appointments of Victoria Sena and Samuel Ogunsalu as Non-Executive Directors of the Company, subject to standard regulatory due diligence. Proposed Director Appointments Victoria Sena founded Cherrybank Consulting Limited in 2019 to assist clients in the areas of governance, operations, risk, and compliance. Previously Victoria spent eight years at the Bank of…

#HVO hVIVO PLC – Proposed Secondary Placing of Ordinary Shares February 14, 2024 – Posted in: hVIVO (HVO)

#TSP TruSpine Technologies PLC – Proposed Director Appointments & Update September 18, 2023 – Posted in: Blog, TruSpine Plc (TSP)

Address

Contact

Social

LEGAL